publication venue for
- The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management. 24:1112-1120. 2022
- Cardiovascular risk assessment tools in Asia. 24:369-377. 2022
- Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network. 24:213-223. 2022
- Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network. 23:422-434. 2021
- Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network. 23:411-421. 2021
- Low levels of awareness, treatment, and control of hypertension in Andean communities of Ecuador. 22:1530-1537. 2020
- Comparison of awake ambulatory blood pressure and automated office blood pressure using linear regression analysis in untreated patients in routine clinical practice. 20:1696-1702. 2018
- Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions. 20:33-38. 2018
- Office blood pressure is lower than awake ambulatory blood pressure at lower targets for treatment. 19:1210-1213. 2017
- Choosing the optimal method of blood pressure measurement for limited-resource rural communities in the “Community Health Assessment Program-Philippines”. 19:899-903. 2017
- The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries. 18:600-605. 2016
- Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction. 12:277-283. 2010
- Barriers to Hypertension Screening, Treatment and Control as Reported by Patients and Healthcare Providers: A Systematic Review of Qualitative and Quantitative Observational Studies 2013
- Effects of Dulaglutide, A GLP-1 Agonist, on Ambulatory Diurnal and Nocturnal Blood Pressure in Patients with Type 2 Diabetes 2013